linaprazan

Small moleculeexperimental

Clinical trial activity

12 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
8
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started Feb 21, 2017 (NCT03105375)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

Cc1cccc(C)c1CNc1cc(C(=O)NCCO)cn2c(C)c(C)nc12
Mol. weight
366.47 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • x842

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07037875Phase 3Sep 30, 2025Cinclus Pharma AG
NCT07294846Phase 1Sep 8, 2025Sinorda Biomedicine
NCT05742984Phase 1Jan 26, 2023Cinclus Pharma AG
NCT05633147Phase 1Nov 27, 2022Cinclus Pharma AG, Clinical Trial Consultants AB
NCT05627518Phase 1Nov 15, 2022Cinclus Pharma AG, CRS d.o.o.
NCT05469854Phase 1Jul 13, 2022Cinclus Pharma AG, Clinical Trial Consultants AB
NCT07107672Phase 1Jun 15, 2022Bengbu Medical College, Sinorda Biomedicine
NCT05055128Phase 2Aug 16, 2021Cinclus Pharma AG, Parexel
NCT07079540Phase 3Jun 24, 2021Sinorda Biomedicine
NCT04531475Phase 2Jan 22, 2019Sinorda Biomedicine
NCT04293965Phase 1Oct 23, 2018Sinorda Biomedicine
NCT03105375Early Phase 1 (Phase 1)Feb 21, 2017Cinclus Pharma AG, Clinical Trial Consultants AB
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cinclus Pharma AGFor profit7732017
Sinorda BiomedicineFor profit5532018
Clinical Trial Consultants ABFor profit3012017
Bengbu Medical CollegeAcademic/Hospital1012022
CRS d.o.o.For profit1012022
ParexelFor profit1012021
6 organizations
Page 1 / 1